- AU$213.55m
- AU$208.63m
- AU$60.12m
- 100
- 38
- 91
- 87
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 18.62 | ||
| PEG Ratio (f) | 1.8 | ||
| EPS Growth (f) | 11.51% | ||
| Dividend Yield (f) | 3.02% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.94 | ||
| Price to Tang. Book | 5.79 | ||
| Price to Free Cashflow | 22.99 | ||
| Price to Sales | 3.55 | ||
| EV to EBITDA | 13.07 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 24.81% | ||
| Return on Equity | 18.04% | ||
| Operating Margin | 23.36% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 29.09 | 31.29 | 40.01 | 55.26 | 60.12 | 60.9 | 67.3 | 15.67% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +41.42 | +43.01 | +34.18 | +25.18 | +15.12 | +16.3 | +10.67 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
XRF Scientific Limited is an Australia-based company, which manufactures and sells chemicals, equipment and accessories to production mines, construction material companies and commercial analytical laboratories, in Australia and overseas. These finished goods are primarily used in the preparation of samples for analysis. The Company's segments include Capital Equipment, Precious Metals and Consumables. The Capital Equipment segment manufactures automated fusion equipment, high temperature test and production furnaces, laboratory jaw crushers and general laboratory equipment. The Precious Metals segment manufactures products for the laboratory and industrial platinum alloy markets. The Consumables segment manufactures chemicals and other supplies for analytical laboratories. Its products and services include Fusion Equipment, Flux & Chemicals, Platinum Labware, Precision Platinum and Lab Equipment. Its subsidiaries include XRF Chemicals Pty Ltd, XRF Labware Pty Ltd and others.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 9th, 2004
- Public Since
- October 31st, 2006
- No. of Shareholders
- 3,687
- Sector
- Office Equipment
- Industry
- Technology
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 140,493,192
- Address
- 86 Guthrie Street, Osborne Park, PERTH, 6017
- Web
- https://www.xrfscientific.com
- Phone
- +61 892440600
- Auditors
- BDO Audit (WA) PTY LTD
Upcoming Events for XRF
XRF Scientific Ltd Annual Shareholders Meeting
Similar to XRF
Trajan group
Australian Stock Exchange - SEATS
FAQ
What is the XRF Scientific share price?
As of Today at 24:13 UTC, shares in XRF Scientific are trading at AU$1.52. This share price information is delayed by 15 minutes.
How has the XRF Scientific share price performed this year?
Shares in XRF Scientific last closed at AU$1.52 and the price had moved by +10.95% over the past 365 days. In terms of relative price strength the XRF Scientific share price has outperformed the ASX All Ordinaries Index by +6.93% over the past year.
What are the analyst and broker recommendations for XRF Scientific?
The overall consensus recommendation for XRF Scientific is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the XRF Scientific dividend yield?
The XRF Scientific dividend yield is 2.57% based on the trailing twelve month period.
Does XRF Scientific pay a dividend?
Last year, XRF Scientific paid a total dividend of AU$0.04, and it currently has a trailing dividend yield of 2.57%. We do not have any data on when XRF Scientific is to next pay dividends.
When does XRF Scientific next pay dividends?
We do not have data on when XRF Scientific is to next pay dividends. The historic dividend yield on XRF Scientific shares is currently 2.57%.
How do I buy XRF Scientific shares?
To buy shares in XRF Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of XRF Scientific?
As of the previous close price of AU$1.52, shares in XRF Scientific had a market capitalisation of AU$213.55m.
Where are XRF Scientific shares listed?
Here are the trading details for XRF Scientific:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: XRF
What kind of share is XRF Scientific?
Based on an overall assessment of its quality, value and momentum XRF Scientific is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a XRF Scientific share price forecast for 2025?
The analyst consensus target price for shares in XRF Scientific is AU$2.22. That is 46.05% above the last closing price of AU$1.52.
Analysts covering XRF Scientific currently have a consensus Earnings Per Share (EPS) forecast of AU$0.08 for the next financial year.
Find out moreWhat is the trend in the XRF Scientific share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like XRF Scientific. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -2.27%.
As of the last closing price of AU$1.52, shares in XRF Scientific were trading -10.49% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the XRF Scientific PE Ratio?
The XRF Scientific PE ratio based on its reported earnings over the past 12 months is 18.62. The shares last closed at AU$1.52.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of XRF Scientific?
XRF Scientific's management team is headed by:
- Vance Stazzonelli - CEO
- Andrew Watson - SEC
- David Brown - NED
- Frederick Grimwade - NID
- David Kiggins - NID